Skip to content

Peking University Birth Cohort in Weifang (PKUBC-WF)

Peking University Birth Cohort in Weifang

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06234332
Enrollment
2800
Registered
2024-01-31
Start date
2024-02-01
Completion date
2043-12-31
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Child Development, Gestational Diabetes, Gestational Hypertension, Health Problems in Pregnancy, Mother-Infant Interaction, Obesity, Pregnancy Outcomes, Preterm Birth

Brief summary

The PKUBC-WF is a prospective cohort study carried out in Weifang city of Shandong, China. The primary aim of this study is to investigate the short-term and long-term effects of pre-pregnant and prenatal exposure on maternal and child health. Data are collected regarding environmental, nutritional and lifestyle exposures as well as short-term and long-term health outcomes of mothers and their children from birth to before 18 years old. Biological samples including peripheral blood, urine, placenta, umbilical cord, cord blood, and faeces are also collected.

Detailed description

Maternal and child health is of great concern globally. Early life phase of a fetus and infant is a critical period for the development of health and disease in the whole life. Exposure of negative environmental, nutritional and lifestyle factors in pregnant women during this period can have adverse effects on fetal and infant. In addition, for mothers, complications during pregnancy could also have a negative effect on long-term health of mothers, such as diabetes, hypertension. Thus, the Peking University Birth Cohort in Weifang is primarily aimed to investigate the short-term and long-term effects of pre-pregnant and prenatal exposure on maternal and child health. Data are collected regarding environmental, nutritional and lifestyle exposures as well as short-term and long-term health outcomes of mothers, husbands and their children from birth to before 18 years old. Biological samples including peripheral blood, urine, placenta, umbilical cord, cord blood, and faeces samples are also collected.

Interventions

OTHERNo Interventions

No intervention This is an observational study without any intervention

Sponsors

National Natural Science Foundation of China
CollaboratorOTHER_GOV
Peking University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnant woman 1. Pregnant women, 6-13\^+6 gestational weeks 2. Resided in Weifang in the past half years and have no plan to move out after delivery 3. Pregnant women who plan to have antenatal care and delivery in Weifang maternal&Child Hospital. 4. Pregnant women who is willing to participate in this study with informed consent * Pregnant woman's husband 1. His wife was eligible for enrollment 2. He is the biological father of the child (his wife's current pregnancy) 3. Pregnant women's husband who is willing to participate in this study with informed consent * Offspring 4. Children born to pregnant women who met the inclusion criteria after enrolling in this study. 5\. Before the age of 8 years, his/her mother provided written informed consent. 6. After 8 years old, he/she agreed to continue this study and signed the informed consent.

Exclusion criteria

* Participants who cannot communicate normally.

Design outcomes

Primary

MeasureTime frameDescription
Numbers and morbidity of participants with pregnancy complicationsAt deliveryIncluding gestational diabetes, gestational hypertension, anemia, and hypothyroidism during pregnancy
Numbers and morbidity of participants with adverse pregnancy outcomesAt deliveryIncluding preterm birth, low birth weight, macrosomia, abortion, stillbirth, and birth defects.

Secondary

MeasureTime frameDescription
Early Child developmentAge at 6 weeks, 6 months and 12 monthsMeasured by Ages&Stages Questionnaires (ASQ).There are 6 questions in each of 5 domains of development: communication, gross motor, fine motor, problem-solving skills, and adaptive skills. Each question is given a 10 (yes), 5 (sometimes), or 0 (not yet) score according to the parents' answers. The sum scores (range from 0 to 300) and scores for each domain (range from 0 to 60) are calculated. Chinese norms are available for each domain, and any domain screened \<2 SDs below the mean is considered a positive screening. A higher ASQ score means better development.
Incidence of diabetes mellitus in women6 weeks after delivery and 3 years after deliveryMeasured by health professionals in clinic
Incidence of hypertension in women6 weeks after delivery and 3 years after deliveryMeasured by health professionals in clinic
Incidence of child overweight and obesityAt birth and age at 6 weeks, 6 months, 12 months, 2 years, 3 years, 6 years, 9 years, 12 years, 15 years, and 17 yearsMeasured by health professionals in clinic
Weight in kilogram changes during childhoodAt birth and age at 6 weeks, 6 months, 12 months, 2 years, 3 years, 6 years, 9 years, 12 years, 15 years, and 17 yearsMeasured by health professionals in clinic
Incidence of attention-deficit/hyperactivity disorder in childrenAge at 6 yearsMeasured by The Child Behavior Checklist (CBC) scale
Incidence of anxiety in adolescentsAge at 9 years, 12 years, 15 years, and 17 yearsMeasured by Social Anxiety Scale for Adolescents (SAS-A) scale
Incidence of depression in adolescentsAge at 9 years, 12 years, 15 years, and 17 yearsMeasured by Beck Depression Inventory-II (BDI-II) scale
Incidence of autism spectrum disorder in childrenAge at 2 years, 3 yearsMeasured by The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-CHAT-R/F) and Autism Behavior Checklist (ABC) scales
Height in centimeter changes during childhoodAt birth and age at 6 weeks, 6 months, 12 months, 2 years, 3 years, 6 years, 9 years, 12 years, 15 years, and 17 yearsMeasured by health professionals in clinic

Countries

China

Contacts

Primary ContactHaijun Wang, Ph.D
whjun1@bjmu.edu.cn86-010-82805583
Backup ContactJue Liu, Ph.D
jueliu@bjmu.edu.cn86-13426455743

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026